基质金属蛋白酶及其抑制剂与糖尿病肾病的关系
被引量:2
摘要
糖尿病肾病(DN)是引起终末期肾病最主要原因之一.但引起DN发生及发展的具体机制至今仍不完全明确.DN的早期病理改变是系膜区扩张,主要是由于细胞外基质(ECM)沉积和系膜细胞增生所致;肾小球基底膜(GBM)增厚也在早期可见,主要是由于ECM代谢失衡.由于在正常肾脏ECM重构中系膜细胞产生的基质金属蛋白酶(MMPs)负责了70%的ECM代谢,因此认为DN的发生发展与肾内MMPs的代谢失调密切相关.
出处
《中华临床医师杂志(电子版)》
CAS
2012年第21期6862-6864,共3页
Chinese Journal of Clinicians(Electronic Edition)
二级参考文献27
-
1Kawazu S, Tomono S, Shimizu M, Kato N, Ohno T, Ishii C,et al. The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. J Diabetes Complications 1994; 8: 13-17.
-
2Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L,Papadopoulos N, et al. Migration of cultured vascular smooth muscle ceils through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 1994; 75:41-54.
-
3Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF,Seifert RA, Coats S, et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery.Circ Res 1999; 85:1179-1185.
-
4Ye S, Humphries S, Henney A. Matrix metalloproteinases:implication in vascular matrix remodeling during atherogenesis.Clin Sci 1998; 94: 103-110.
-
5Knittel T, Mehde M, Kobold D, Saile B, Dinter C, Ramadori G. Expression patterns of matrix metalloproteinase and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1. J Hepatol 1999;30: 48-60.
-
6Lee E, Vaughan DE, Parikh SH, Grodzinsky A J, Libby P,Lark MW, et al. Regulation of matrix metalloproteinases and plasminogen activator inhibitor- 1 synthesis by plasminogen in cultured human vascular smooth muscle cells. Circ Res1996: 78: 44-49.
-
7Kenagy RD, Nikkari ST, Welgus HG, Clowes AW. Heparin inhibits the induction of three matrix metalloproteinases(stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. J Clin Invest 1994; 93: 1987-1993.
-
8Li YY, McTieman CF, Feldman AM. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 2000; 46: 214-224.
-
9Spinale FG, Coker ML, Bond BR, Zellner JL. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Cardiovasc Res2000; 46: 225-238.
-
10Li Z, Li L, Zielke HR, Cheng L, Xiao R, Crow MT, et al.Increased expression of 72-kD type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 1996;148: 121-128.
共引文献29
-
1王莉,黄尚珍,罗燕军.银杏叶提取物对老年大鼠肝脏的保护作用[J].河北医科大学学报,2005,26(6):413-417. 被引量:5
-
2顾秀峰,刘勇,刘乃丰.糖基化终产物对大鼠主动脉平滑肌细胞MMP-2表达的影响[J].天津医药,2006,34(12):871-874. 被引量:1
-
3罗海燕,张卓,陈昌华.葛根素对实验性糖尿病大鼠主动脉Ⅳ型胶原基因表达的抑制作用[J].沈阳药科大学学报,2007,24(6):360-364. 被引量:2
-
4陈蔚,叶红英,俞茂华.黄芪多糖对糖尿病心肌胶原代谢的影响[J].上海交通大学学报(医学版),2007,27(10):1206-1209. 被引量:9
-
5雷凤英,覃远汉,裴娟,胡鹏.基质金属蛋白酶及金属蛋白酶组织抑制因子-1在肾小球硬化大鼠中的表达和意义[J].实用儿科临床杂志,2007,22(23):1812-1813. 被引量:8
-
6赵俐丽,叶山东.血管紧张素转换酶抑制剂防治糖尿病肾病的作用机制[J].国外医学(老年医学分册),2008,29(4):168-172. 被引量:4
-
7苗春生,石艳,于晓艳,李才.胡芦巴对糖尿病大鼠肾脏基质金属蛋白酶-2活性的影响[J].吉林大学学报(医学版),2008,34(1):87-89. 被引量:2
-
8鄢艳,陈钦开,王瑜,王缨,张莉.霉酚酸酯对糖尿病大鼠肾脏基质金属蛋白酶9、转化生长因子β1表达的影响[J].中华肾脏病杂志,2009,25(7):543-547. 被引量:2
-
9刘育军,彭文,赵燕俐,王浩,孙仲伦.柴芩肾安方对IgA肾病大鼠肾小球Ⅳ型胶原和基质金属蛋白酶-2/基质金属蛋白酶组织抑制物-2的影响[J].上海医学,2009,32(9):823-825. 被引量:1
-
10毛春谱,李小毅,张红梅,林桂芬.苯那普利对糖尿病大鼠肾皮质MMP-2、TIMP-2和C-IV表达的影响[J].苏州大学学报(医学版),2009,29(4):632-635.
同被引文献19
-
1中华医学会糖尿病学分会.中国2型糖尿病防治指南[M].北京:北京大学医学出版社,2007:32.
-
2Leem B. Biochemistry and molecule cell biology of diabetic complica- tion of mellitus[ J]. Ann Rev Biochem Nat,2011,414:81320.
-
3Awazu M, Ishikura K, Hida M, et al. Mechanisms of mitogeuaeti- rated protein kinase activation in experimental diabetes[ J]. J Am Soc Nephrol, 1999,10 : 738 -745.
-
4Lai KC, Huang AC, Hsu SC, et al. Benzyl isothioeyanate ( BITC ) in- hibits migration and invasion of human colon cancer HT29 cells by in- hibiting matrix metalloproteinase - 2/- 9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway [ J ]. J Agrie Food Chem, 2010,58:2935 - 2940.
-
5Gross JI, De - Azevedo M J, Silveiro SP, et al. Diabetic nephropathy : Diagnosis, prevention and treatment [ J ]. Diabetes Care, 2005,28 : 164 - 176.
-
6Kathryn M. Thrailkill,Cynthia S. Moreau,Gael E. Cockrell,Chan-Hee Jo,Robert C. Bunn,Alba E. Morales-Pozzo,Charles K. Lumpkin,John L. Fowlkes.Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus[J]. Endocrine . 2010 (2)
-
7Manabu Wada,Hikaru Nagasawa,Keiji Kurita,Shingo Koyama,Shigeki Arawaka,Toru Kawanami,Katsushi Tajima,Makoto Daimon,Takeo Kato.Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects[J]. Journal of the Neurological Sciences . 2007 (1)
-
8Dimitrios N. Tziakas,Georgios K. Chalikias,John T. Parissis,Eleni I. Hatzinikolaou,Elias D. Papadopoulos,Grigorios A. Tripsiannis,Evropi G. Papadopoulou,Ioannis K. Tentes,Spilios M. Karas,Dimitrios I. Chatseras.Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration[J]. International Journal of Cardiology . 2003 (2)
-
9Izidoro-Toledo Tatiane C,Guimaraes Danielle A,Belo Vanessa A,Gerlach Raquel F,Tanus-Santos Jose Eduardo.Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells. Naunyn-Schmiedeberg’s archives of pharmacology . 2011
-
10马真金.甘肃人工栽培红芪的质量分析[J].西部中医药,2011,24(8):15-16. 被引量:5
二级引证文献25
-
1黄菡雪,蒋志鹏,陈雪品,张滢,郝世楠,韩淑英.中药单体对db/db小鼠糖尿病肾脏保护作用的研究进展[J].中国执业药师,2016,13(7):31-34. 被引量:2
-
2牛江涛,曹瑞,张泽国,徐富菊,李越峰.红芪多糖的提取分离及药理作用研究进展[J].中国药房,2017,28(1):130-133. 被引量:27
-
3陈宁,张影坤,覃妮,黄仁彬,焦杨.吊竹梅水提物对糖尿病肾损伤小鼠的肾保护作用[J].中国临床药理学杂志,2017,33(2):131-135. 被引量:4
-
4石桂珍,和彩铃,王东旭,南向萍,金智生.金智生教授治疗糖尿病肾病的临床经验[J].光明中医,2017,32(3):327-329. 被引量:9
-
5吴张浩.活血利水中药复方对高血压病早期肾损害的临床疗效研究[J].临床医学研究与实践,2017,2(7):109-110. 被引量:3
-
6周丽霞,张娜娜.糖尿病并发症的中医干预治疗及常用中药功用探讨[J].湖北中医杂志,2017,39(9):37-42. 被引量:4
-
7骆少团,李建业.美托洛尔联合阿托伐他汀治疗老年不稳定心绞痛的效果评价[J].黑龙江医药,2017,30(2):303-305. 被引量:2
-
8单玫,高守铭,叶玉莺.红芪多糖对链脲佐菌素诱导糖尿病模型大鼠视网膜VEGF与PEDF及CRP水平影响研究[J].四川中医,2017,35(11):54-57. 被引量:10
-
9周丹,张芃,张照英,安艳红.维持性血液透析患者血清基质金属蛋白酶与颈动脉硬化及钙磷代谢相关性研究[J].解放军医药杂志,2018,30(2):37-40. 被引量:8
-
10林忠伟,王卓,喻婵,张炽明,李稳磊,肖文豪.赤芍总苷对高血压大鼠血管重构基质金属蛋白酶9、金属蛋白酶组织抑制因子1和血管壁氧化应激的干预作用[J].中国动脉硬化杂志,2018,26(8):774-778. 被引量:20
-
1陈广平,郭慕依,张月娥,张锦生,陈琦.肝素对人肾小球系膜细胞生长的影响及机制[J].上海医科大学学报,1997,24(5):395-396. 被引量:1
-
2祖秀梅.老年胃肠道肿瘤患者化疗疗效及对生存质量的影响[J].河北医药,2013,35(4):570-571. 被引量:10
-
3任国辉,叶任高,李幼姬,董秀清.大鼠加速型抗肾小球基底膜(GBM)肾炎的研制[J].中国实验动物学报,1994,2(2):102-106. 被引量:4
-
4姚新明,叶山东.基质金属蛋白酶-9与糖尿病肾病关系的研究进展[J].中国临床保健杂志,2007,10(5):542-545. 被引量:8
-
5王睿,杨欣.盆底功能障碍性疾病基质金属蛋白酶及其抑制剂的研究进展[J].中国妇产科临床杂志,2011,12(4):314-315. 被引量:4
-
6林峰.基质金属蛋白酶及其抑制剂与大肠癌肝转移的研究进展[J].肿瘤学杂志,2002,8(3):174-176. 被引量:4
-
7王剑火,施作霖,陈梓甫.基质金属蛋白酶及其抑制剂与几种常见的泌尿系肿瘤[J].临床与实验病理学杂志,2000,16(3):247-248. 被引量:3
-
8王岩,刘晓霞,侯正文,柳春晖,马秀萍,陈丽萍,贾支红,方虹.基质金属蛋白酶及其抑制剂在乳腺癌转移、浸润中的作用[J].临床与实验病理学杂志,2002,18(3):273-275. 被引量:12
-
9吴登龙.基质金属蛋白酶及其抑制剂与泌尿系肿瘤的浸润与转移[J].国外医学(泌尿系统分册),1998,18(1):30-33. 被引量:10
-
10许璟,刘伟国.基质金属蛋白酶及其抑制剂与脑肿瘤侵袭转移的关系[J].浙江创伤外科,2002,7(2):138-140.